Acute Respiratory Distress Syndrome Pipeline Review | Latest FDA, EMA, and PMDA Approvals, Novel and Emerging Therapies, Clinical Trials, and Treatment Outlook | AVM Biotechnology, Aqualung Therapeutics, Cynata Therapeutics, Histocell, BioMarck Pharmaceut

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Acute Respiratory Distress Syndrome pipeline constitutes 15+ key companies continuously working towards developing 15+ Acute Respiratory Distress Syndrome treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.

"Acute Respiratory Distress Syndrome Pipeline Insight, 2023" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Acute Respiratory Distress Syndrome Market.

The Acute Respiratory Distress Syndrome Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.

Some of the key takeaways from the Acute Respiratory Distress Syndrome Pipeline Report:
https://www.delveinsight.com/sample-request/acute-respiratory-distress-syndrome-ards-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
• Companies across the globe are diligently working toward developing novel Acute Respiratory Distress Syndrome treatment therapies with a considerable amount of success over the years.
• Acute Respiratory Distress Syndrome companies working in the treatment market are Meridigen Biotech, AVM Biotechnology, Aqualung Therapeutics, Cynata Therapeutics, Histocell, BioMarck Pharmaceuticals, Exvastat, Vasomune Therapeutics, Athersys, and others, are developing therapies for the Acute Respiratory Distress Syndrome treatment
• Emerging Acute Respiratory Distress Syndrome therapies in the different phases of clinical trials are- UMC 119 06, AVM0703, ALT-100, CYP 001, HCR040, BIO-11006, Imatinib, AV 001, MultiStem cell therapy, and others are expected to have a significant impact on the Acute Respiratory Distress Syndrome market in the coming years.
• In April 2022, A landmark Phase 3 clinical research using Direct Biologics' investigational EV drug ExoFlow to treat Acute Respiratory Distress Syndrome (ARDS) has been given the FDA's approval.
• In January 2022, According to Veru, the FDA has given Sabizabulin a fast-track designation for the treatment of COVID-19 patients who are hospitalized and at a high risk of suffering acute respiratory distress syndrome.
• In April 2020, Athersys initiated an open-label, double-blinded, randomized, placebo-controlled PhaseII/III study to evaluate the safety and efficacy of MultiStem therapy in subjects with moderate to severe Acute Respiratory Distress Syndrome (ARDS) due to pathogens including COVID-19

Acute Respiratory Distress Syndrome Overview
Low blood oxygen levels are a result of the dangerous lung ailment acute respiratory distress syndrome (ARDS). People who have ARDS typically become unwell as a result of another illness or a serious injury. In ARDS, surfactant disintegrates and fluid accumulates inside the lungs' small air sacs. A frothy material called asurfactant maintains the lungs open so that one can breathe.

Get a Free Sample PDF Report to know more about Acute Respiratory Distress Syndrome Pipeline Therapeutic Assessment-
https://www.delveinsight.com/report-store/acute-respiratory-distress-syndrome-ards-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Emerging Acute Respiratory Distress Syndrome Drugs Under Different Phases of Clinical Development Include:
• UMC 119 06: Meridigen Biotech
• AVM0703: AVM Biotechnology
• ALT-100: Aqualung Therapeutics
• CYP 001: Cynata Therapeutics
• HCR040: Histocell
• BIO-11006: BioMarck Pharmaceuticals
• Imatinib: Exvastat
• AV 001: Vasomune Therapeutics
• MultiStem cell therapy: Athersys

Acute Respiratory Distress Syndrome Route of Administration
Acute Respiratory Distress Syndrome pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as
• Intravenous
• Oral
• Subcutaneous
• Molecule Type

Acute Respiratory Distress Syndrome Molecule Type
Acute Respiratory Distress Syndrome Products have been categorized under various Molecule types, such as
• Immunoglobulin
• Monoclonal antibodies
• Protein
• Recombinant fusion proteins
• Small molecules
• Vaccine
• Product Type

Acute Respiratory Distress Syndrome Pipeline Therapeutics Assessment
• Acute Respiratory Distress Syndrome Assessment by Product Type
• Acute Respiratory Distress Syndrome By Stage and Product Type
• Acute Respiratory Distress Syndrome Assessment by Route of Administration
• Acute Respiratory Distress Syndrome By Stage and Route of Administration
• Acute Respiratory Distress Syndrome Assessment by Molecule Type
• Acute Respiratory Distress Syndrome by Stage and Molecule Type

DelveInsight's Acute Respiratory Distress Syndrome Report covers around 15+ products under different phases of clinical development like
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration

Further Acute Respiratory Distress Syndrome product details are provided in the report. Download the Acute Respiratory Distress Syndrome pipeline report to learn more about the emerging Acute Respiratory Distress Syndrome therapies at:
https://www.delveinsight.com/sample-request/acute-respiratory-distress-syndrome-ards-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Some of the key companies in the Acute Respiratory Distress Syndrome Therapeutics Market include:
Key companies developing therapies for Acute Respiratory Distress Syndrome are - Faron Pharmaceuticals6, BioMarck Pharmaceuticals, GE Healthcare, Hamilton Company, Athersys, United Therapeutics, Apeptico Forschung, Fisher & Paykel Healthcare Limited, NRx Pharmaceuticals, Inc., HEALIOS K.K, Dragerwerk AG & Co. KGaA, ALung Technologies, Inc ( LivaNova PLC), and others.

Acute Respiratory Distress Syndrome Pipeline Analysis:
The Acute Respiratory Distress Syndrome pipeline report provides insights into
• The report provides detailed insights about companies that are developing therapies for the treatment of Acute Respiratory Distress Syndrome with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Acute Respiratory Distress Syndrome Treatment.
• Acute Respiratory Distress Syndrome key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Acute Respiratory Distress Syndrome Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Acute Respiratory Distress Syndrome market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.

Download Sample PDF Report to know more about Acute Respiratory Distress Syndrome drugs and therapies-
https://www.delveinsight.com/sample-request/acute-respiratory-distress-syndrome-ards-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Acute Respiratory Distress Syndrome Pipeline Market Drivers
• Increasing R&D activities, increasing incidence of ARDS, non-competitive Landscape are some of the important factors that are fueling the Acute Respiratory Distress Syndrome Market.

Acute Respiratory Distress Syndrome Pipeline Market Barriers
• However, lack of awareness about the disease, mechanical ventilation for management, missed-diagnoses of ARDS and other factors are creating obstacles in the Acute Respiratory Distress Syndrome Market growth.

Scope of Acute Respiratory Distress Syndrome Pipeline Drug Insight
• Coverage: Global
• Key Acute Respiratory Distress Syndrome Companies: Meridigen Biotech, AVM Biotechnology, Aqualung Therapeutics, Cynata Therapeutics, Histocell, BioMarck Pharmaceuticals, Exvastat, Vasomune Therapeutics, Athersys, and others
• Key Acute Respiratory Distress Syndrome Therapies: UMC 119 06, AVM0703, ALT-100, CYP 001, HCR040, BIO-11006, Imatinib, AV 001, MultiStem cell therapy, and others
• Acute Respiratory Distress Syndrome Therapeutic Assessment: Acute Respiratory Distress Syndrome current marketed and Acute Respiratory Distress Syndrome emerging therapies
• Acute Respiratory Distress Syndrome Market Dynamics: Acute Respiratory Distress Syndrome market drivers and Acute Respiratory Distress Syndrome market barriers

Request for Sample PDF Report for Acute Respiratory Distress Syndrome Pipeline Assessment and clinical trials-
https://www.delveinsight.com/sample-request/acute-respiratory-distress-syndrome-ards-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1. Acute Respiratory Distress Syndrome Report Introduction
2. Acute Respiratory Distress Syndrome Executive Summary
3. Acute Respiratory Distress Syndrome Overview
4. Acute Respiratory Distress Syndrome- Analytical Perspective In-depth Commercial Assessment
5. Acute Respiratory Distress Syndrome Pipeline Therapeutics
6. Acute Respiratory Distress Syndrome Late Stage Products (Phase II/III)
7. Acute Respiratory Distress Syndrome Mid Stage Products (Phase II)
8. Acute Respiratory Distress Syndrome Early Stage Products (Phase I)
9. Acute Respiratory Distress Syndrome Preclinical Stage Products
10. Acute Respiratory Distress Syndrome Therapeutics Assessment
11. Acute Respiratory Distress Syndrome Inactive Products
12. Company-University Collaborations (Licensing/Partnering) Analysis
13. Acute Respiratory Distress Syndrome Key Companies
14. Acute Respiratory Distress Syndrome Key Products
15. Acute Respiratory Distress Syndrome Unmet Needs
16 . Acute Respiratory Distress Syndrome Market Drivers and Barriers
17. Acute Respiratory Distress Syndrome Future Perspectives and Conclusion
18. Acute Respiratory Distress Syndrome Analyst Views
19. Appendix
20. About DelveInsight

Related Reports:

Acute Respiratory Distress Syndrome Market
https://www.delveinsight.com/report-store/acute-respiratory-distress-syndrome-ards-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Acute Respiratory Distress Syndrome Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom),

Acute Respiratory Distress Syndrome Epidemiology
https://www.delveinsight.com/report-store/acute-respiratory-distress-syndrome-ards-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Acute Respiratory Distress Syndrome Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Cholangiocarcinoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Latest Reports:
Patient Monitoring Devices Market https://www.delveinsight.com/report-store/patient-monitoring-devices-market?utm_source=reportstore&utm_medium=promotion&utm_campaign=gpr
Patient Monitoring Devices Market By Type Of Devices (Neuromonitoring Devices, Cardiac Monitoring Devices, Respiratory Monitoring Devices, Hemodynamic Monitoring Devices, Blood Glucose Monitoring Systems, And Others), By Application (Cardiology, Neurology, Respiratory, And Others), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, Home Care Settings, And Others), by geography, is anticipated to grow at a significant CAGR till 2028 owing to the growing prevalence of various chronic disorders and integration of advanced technology in the products.

Typhoid Market https://www.delveinsight.com/report-store/typhoid-fever-market?utm_source=reportstore&utm_medium=promotion&utm_campaign=gpr
DelveInsight's "Typhoid Fever Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Typhoid Fever, historical and forecasted epidemiology as well as the Typhoid Fever market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Vascular Graft Devices Market https://www.delveinsight.com/report-store/vascular-grafts-market?utm_source=reportstore&utm_medium=promotion&utm_campaign=gpr
Vascular Graft Devices Market By Product Type (Endovascular Grafts [Abdominal And Thoracic], Access Grafts, Peripheral Grafts, And Others), By Type (Knitted, Woven, And Others), By Material (Synthetic[ Polytetrafluoroethylene [PTFE], Polyester, Polyurethane], Biological, And Others), By End User (Hospitals, Ambulatory Surgical Centers, And Others), by geography is expected to register commendable revenue growth at a steady CAGR forecast till 2028.

Vascular Stents Market https://www.delveinsight.com/report-store/vascular-stents-market?utm_source=reportstore&utm_medium=promotion&utm_campaign=gpr
Vascular Stents Market By Product Type (Coronary Stents, Peripheral Stents [Carotid Stents, Iliac Stents, Femoral Stents, Femoral Stents, Other], Evar Stent Grafts [Abdominal Aortic Aneurysm Stents, Thoracic Aortic Aneurysm Stents]), By Type (Bare-Metal Stents, Drug-Eluting Stents), By Material (Metal And Polymer), By Mode Of Delivery (Balloon-Expandable Stents And Self Expandable Stents), By End-User (Hospitals And Ambulatory Surgical Centers), by geography, is expected to grow at a noteworthy CAGR forecast till 2028.

Ventricular Assist Devices Market https://www.delveinsight.com/report-store/ventricular-assist-devices-vad-market?utm_source=reportstore&utm_medium=promotion&utm_campaign=gpr
Ventricular Assist Devices Market By Product Type (Left Ventricular Assist Devices, Right Ventricular Assist Devices, And Biventricular Assist Devices), By Application Type (Bridge-To-Transplant [Btt], Destination Therapy, And Others), By Design Type (Transcutaneous Ventricular Assist Devcies And Implantable Ventricular Assist Devices), By Type Of Flow (Pulsatile Flow And Continous Flow), By End User (Hospital And Clinics, Ambulatory Surgical Centers, And Others), by geography is expected to grow at a steady CAGR forecast till 2028.

Resorbable Vascular Scaffolds Market https://www.delveinsight.com/report-store/resorbable-vascular-scaffolds-market?utm_source=reportstore&utm_medium=promotion&utm_campaign=gpr
DelveInsight's 'Resorbable Vascular Scaffolds - Market Insight, Competitive Landscape and Market Forecast, 2028' report delivers an in-depth understanding of Resorbable Vascular Scaffolds and the historical and forecasted Resorbable Vascular Scaffolds market trends, globally, which comprises of North America, Europe, APAC, and RoW.

Vein Illumination Devices Market https://www.delveinsight.com/report-store/vein-illumination-devices-market?utm_source=reportstore&utm_medium=promotion&utm_campaign=gpr
DelveInsight's 'Vein Illumination Devices - Market Insight, Competitive Landscape and Market Forecast, 2028' report delivers an in-depth understanding of Vein Illumination Devices and the historical and forecasted Vein Illumination Devices market trends, globally, which comprises of North America, Europe, APAC, and RoW.

Protein Supplements Market
https://www.delveinsight.com/report-store/protein-supplements-market
Protein Supplements Market By Source (Animal-Based [Whey, Casein, Fish, Eggs, Others], Plant-Based [Soy, Rice, Pea, Spirulina, Others]), By Product Type (Protein Powders, Protein Bars, Ready-To-Drink, And Others), By Application (Sports Nutrition And Functional Foods), By Distribution Channel (Supermarkets And Hypermarkets, E-Commerce, Direct-To-Consumer, Others), by geography is estimated to register growth at a remarkable CAGR forecast during 2022-2027 owing to the growing consumer awareness of having a protein rich diet,

Proteomics Market
https://www.delveinsight.com/report-store/prostate-cancer-market-insight
Proteomics Market By Product & Services (Instrumentation Technology [Spectroscopy, Chromatography, Electrophoresis, Protein Microarrays, X-Ray Crystallography, And Other], Reagents & Consumables, And Software & Services), By Application (Clinical Diagnostics, Drug Discovery, And Others), By End-User (Hospitals, Clinical Laboratories, Pharmaceutical Companies, And Others), and by geography is expected to advance at a respectable CAGR forecast till 2028.

Infrared Thermometer Market
https://www.delveinsight.com/report-store/infrared-thermometer-market
Infrared Thermometer Market By Product Type (Contact Thermometers And Non-Contact Thermometers), By End-User (Food And Beverage Industry, Electronic Industry, Healthcare Industry, And Others), and by geography is expected to advance at a respectable CAGR forecast till 2028 owing to the growing need for robust temperature measuring devices in critical industries and rise in the number of infectious diseases across the globe.

Hemoglobinopathies Market
https://www.delveinsight.com/report-store/sport-nutrition-market
Hemoglobinopathies Market By Indication (Thalassemia, Sickle Cell Anaemia, And Others), By Treatment (Stem Cell Therapy, Blood Transfusion, Iron Chelation Therapy, And Others), and by geography is expected to advance at a respectable CAGR forecast till 2027 owing to the increasing prevalence of various hemoglobin disorders and the increasing research & developmental activities concerning to the hemoglobinopathies across the globe

Sport Nutrition Market
https://www.delveinsight.com/report-store/sport-nutrition-market
The Sports Nutrition Market By Product Type (Sports Drinks And Sports Supplements), By Distribution Channels (Hypermarkets & Supermarkets, E-Commerce, And Others), and by geography is expected to grow at a steady CAGR forecast till 2028 owing to the increasing inclination toward following healthy and active lifestyle and growing importance of sports nutrition among athletes and sportspersons.

Endodontic Devices Market
https://www.delveinsight.com/report-store/endodontic-devices-market
Endodontic Devices Market By Product Type (Instruments [Apex Locators, Endodontic Motors, Endodontic Scalers, Endodontic Lasers, Handpieces, Machine-Assisted Obturation Systems, And Others], Consumables [Obturation, Access Cavity Preparation, Shaping And Cleaning]), By End-User (Dental Hospitals, Dental Clinics, And Others), and by geography is estimated to register growth at a remarkable CAGR during the forecast period from 2023-2028 owing to the rising patient pool associated with dental disorders, poor oral health, leading to increased number of root canal treatments, the increasing population opting for dental aesthetics, among others across the globe.

Contact Us:
Gaurav Bora
gbora@delveinsight.com
+1(919)321-6187
Healthcare Consulting
https://www.delveinsight.com/consulting-services

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

This release was published on openPR.